Practices


Courses Share info On Basics of Billion Dollar Tort

November 10, 2004 - On the September morning Merck pulled its blockbuster pain medicine Vioxx from the market, a group of lawyers was busy taking deposition from the drug maker's former chief medical officer. Read More


Bextra heart risks similar to Vioxx

November 10, 2004 - The arthritis drug Bextra, made by Pfizer Inc., has shown a high incidence of heart attacks and strokes among patients, according to an American Heart Association study. Read More


Army of Attorneys against Merck Convenes on Coast

November 10, 2004 - More than 300 attorneys mustered here to lay legal siege to Merck which withdrew its popular anti-arthritis drug, Vioxx, in September because of evidence that the medication caused heart... Read More


Lawyers bone up on Vioxx Liability

November 10, 2004 - On the September morning Merck pulled its blockbuster pain medicine Vioxx from the market, a group of lawyers was busy taking a deposition from the drug maker's former chief medical officer. Read More


Drugmaker Pfizer under Pressure on Bextra

November 9, 2004 - Drugmaker Pfizer Inc. is in talks with regulators over a likely change to arthritis drug Bextras label to carry a strict warning alerting doctors of the risk of a potentially deadly skin... Read More


Lawyers meet to discuss scope of Vioxx Litigation.

November 9, 2004 - Lawyers meeting to discuss Vioxx litigation say pending lawsuits will show that Merck & Co. Inc. was aware of the arthritis drug's risks before it was taken off the market. Read More


Lawyers Meet to Discuss Scope of Vioxx Litigation

November 9, 2004 - Lawyers meeting on Tuesday to discuss Vioxx litigation say pending lawsuits will show that Merck & Co, Inc. (MRK.N) was aware of the arthritis drug's risks before it was taken off the... Read More


More Worries for Pfizer

November 8, 2004 - Shares of Pfizer fell after the drug giants disclosure that New York Attorney General Eliot Spitzer has asked for information relating to its clinical trials and marketing of certain... Read More


Vioxx shockwaves rock Merck

November 7, 2004 - Merck & Co.'s Pandora's box has been opened wide, affecting much more than just the 20 million users of Vioxx. Read More


Pfizer says FDA Warning likely for Bextra

November 6, 2004 - Bextra, a Pfizer pain drug that received a sales boost when Merck's Vioxx was pulled from the market, will probably be tagged with the most prominent type of safety warning used by the FDA. Read More


back to top